Implementation of Diagnostic Biomarker Testing in Lung Cancer: Real-World Data in Japan

被引：0
|
作者：
Yatabe, Y. [1 ]
Yoshiki, Y. [2 ]
Matsumura, K. [2 ]
Togo, K. [2 ]
Kikkawa, H. [2 ]
Masters, E. [3 ]
Iadeluca, L. [3 ]
Becnel, L. [4 ]
Emir, B. [3 ]
Wiltshire, R. [5 ]
Nishio, K. [6 ]
机构：
[1] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, Japan
[2] Pfizer Japan Inc, Tokyo, Japan
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Westlake, TX USA
[5] Pfizer Ltd, Walton Oaks, England
[6] Kindai Univ, Sch Med, Dept Genome Biol, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
real world data; lung cancer; companion diagnosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.08
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [1] Real-World Data of NGS Diagnostic Biomarker Testing for Lung Cancer Patients in Japan
    Takahashi, T.
    Nishio, M.
    Yatabe, Y.
    Nishino, K.
    Yoshiki, Y.
    Shiraiwa, N.
    Emir, B.
    Iadeluca, L.
    Nishio, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1151 - S1152
  • [2] Real-world study of next-generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
    Takahashi, Toshiaki
    Nishio, Makoto
    Nishino, Kazumi
    Yoshiki, Yasumasa
    Shiraiwa, Naoko
    Emir, Birol
    Iadeluca, Laura
    Yatabe, Yasushi
    Nishio, Kazuto
    CANCER SCIENCE, 2023, 114 (06) : 2524 - 2533
  • [3] Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan
    Yatabe, Yasushi
    Yoshiki, Yasumasa
    Matsumura, Koichi
    Togo, Kanae
    Kikkawa, Hironori
    Iadeluca, Laura
    Li, Benjamin
    Nishio, Kazuto
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (03):
  • [4] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments
    Kokkotou, Eleni
    Anagnostakis, Maximilian
    Evangelou, Georgios
    Syrigos, Nikolaos K.
    Gkiozos, Ioannis
    CANCERS, 2024, 16 (07)
  • [6] Role of Real-World Data in Assessing Cardiac Toxicity After Lung Cancer Radiotherapy
    Abravan, Azadeh
    Price, Gareth
    Banfill, Kathryn
    Marchant, Tom
    Craddock, Matthew
    Wood, Joe
    Aznar, Marianne C.
    McWilliam, Alan
    van Herk, Marcel
    Faivre-Finn, Corinne
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Real-world data on severe lung cancer: a multicenter retrospective study
    Wang, Fei
    Xie, Xiaohong
    Wang, Liqiang
    Deng, Haiyi
    Wang, Qian
    Qi, Min
    Guo, Min
    Chen, Juan
    Zhou, Maolin
    Sun, Ni
    Li, Ru
    Yang, Yilin
    He, Zuer
    Lin, Xinqing
    Liu, Ming
    Wu, Di
    Sun, Gengyun
    Zhou, Chengzhi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 460 - +
  • [8] Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database study
    Hess, Lisa M.
    Michael, Diane
    Krein, Peter M.
    Marquart, Tyler
    Sireci, Anthony N.
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 43 - 50
  • [9] Inflammation-based prognostic markers of metastatic pancreatic cancer using real-world data in Japan: The Tokushukai REAl-world Data (TREAD) project
    Shimoyama, Rai
    Imamura, Yoshinori
    Uryu, Kiyoaki
    Mase, Takahiro
    Shiragami, Megumi
    Fujimura, Yoshiaki
    Hayashi, Maki
    Ohtaki, Megu
    Ohtani, Keiko
    Shinozaki, Nobuaki
    Minami, Hironobu
    ONCOLOGY LETTERS, 2024, 27 (03)
  • [10] Biomarker Testing, Targeted Therapy and Clinical Trial Participation by Race Among Patients With Lung Cancer: A Real-World Medicaid Database Study
    Bruno, Debora S.
    Li, Xiaohong
    Hess, Lisa M.
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (03):
12345